2.3 The list price for single infusion is £316,118 (excluding VAT, MIMS [Monthly Index of Medical Specialities] online, accessed February 2023).
2.4 The company has a commercial arrangement. This makes brexucabtagene autoleucel available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.